Peptide length determines the outcome of TCR/peptide-MHCI engagement

Blood

Volumn 121, Issue 7, 2013, Pages 1112-1123

  Ekeruche Makinde, Julia ^a   Miles, John J ^a,b   Van Den Berg, Hugo A ^c   Skowera, Ania ^d,e   Cole, David K ^a   Dolton, Garry ^a   Schauenburg, Andrea J A ^a   Tan, Mai Ping ^a   Pentier, Johanne M ^a   Llewellyn Lacey, Sian ^a   Miles, Kim M ^a   Bulek, Anna M ^a   Clement, Mathew ^a   Williams, Tamsin ^a   Trimby, Andrew ^a   Bailey, Mick ^f   Rizkallah, Pierre ^a   Rossjohn, Jamie ^a,g   Peakman, Mark ^d,e   Price, David A ^a   Burrows, Scott R ^b   Sewell, Andrew K ^a   Wooldridge, Linda ^a   more..

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL CLONING; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; ENZYME SPECIFICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE LENGTH; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE; VACCINATION;

EID: 84874098478     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-437202     Document Type: Article

References (50)

1. Shortman K, Egerton M, Spangrude GJ, Scollay R. The generation and fate of thymocytes. Semin Immunol. 1990;2(1):3-12.
2. Lieber MR. Site-specific recombination in the immune system. FASEBJ. 1991;5(14):2934-2944. (Pubitemid 21905834)
3. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. The nature of molecular recognition byTcells. Nat Immunol. 2003;4(3):217-224.
4. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999;286(5441):958-961.
5. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. Diversity of human alpha beta T cell receptors. Science. 2000; 288(5469):1135.
6. Godfrey DI, Rossjohn J, McCluskey J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity. 2008;28(3):304-314. (Pubitemid 351343861)
7. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem. 2012;287(2):1168-1177.
8. Felix NJ, Allen PM. Specificity of T-cell alloreac-tivity. Nat Rev Immunol. 2007;7(12):942-953.
9. Wucherpfennig KW, Sethi D. T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. Semin Immunol. 2011;23(2): 84-91.
10. Rist M, Smith C, Bell MJ, Burrows SR, Khanna R. Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood. 2009;114(11): 2244-2253.
11. Yin L, Huseby E, Scott-Browne J, et al. A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchableTCR conformers. Immunity. 2011; 35(1):23-33.
12. Stadinski BD, Trenh P, Smith RL, et al. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompat-ibility ligands. Immunity. 2011;35(5):694-704.
13. Willcox BE, Gao GF, Wyer JR, et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 1999;10(3):357-365. (Pubitemid 29165290)
14. Scott DR, Borbulevych OY, Piepenbrink KH, Corcelli SA, Baker BM. Disparate degrees of hy-pervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. J Mol Biol. 2011;414(3):385-400.
15. Macdonald WA, Chen Z, Gras S, et al. T cell al-lorecognition via molecular mimicry. Immunity. 2009;31(6):897-908.
16. Archbold JK, Macdonald WA, Miles JJ, et al. Allo-reactivity between disparate cognate and alloge-neic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry. J Biol Chem. 2006;281(45):34324- 34332. (Pubitemid 46036640)
17. Archbold JK, Macdonald WA, Gras S, et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med. 2009;206(1):209-219.
18. Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol. 2006;27(1):11-16. (Pubitemid 43083559)
19. Skowera A, Ellis RJ, Varela-Calvino R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest. 2008;118(10):3390-3402.
20. Laugel B, van den Berg HA, Gostick E, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007;282(33):23799- 23810. (Pubitemid 47328005)
21. Cole DK, Edwards ES, Wynn KK, et al. Modification of MHC anchor residues generates hetero-clitic peptides that alter TCR binding and T cell recognition. J Immunol. 2010;185(4):2600-2610.
22. Miles JJ, Borg NA, Brennan RM, et al. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol. 2006;177(10):6804-6814. (Pubitemid 44715045)
23. Wynn KK, Fulton Z, Cooper L, et al. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood. 2008;111(8):4283-4292.
24. Tynan FE, Borg NA, Miles JJ, et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem. 2005; 280(25):23900-23909. (Pubitemid 40884878)
25. Wooldridge L, Lissina A, Vernazza J, et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol. 2007;37(5):1323-1333. (Pubitemid 46925316)
26. Wooldridge L, Laugel B, Ekeruche J, et al. CD8 controls T cell cross-reactivity. J Immunol. 2010; 185(8):4625-4632.
27. Wooldridge L, Lissina A, Cole DK, van den Berg HA, Price DA, Sewell AK. Tricks with tetram-ers: how to get the most from multimeric peptide-MHC. Immunology. 2009;126(2):147-164.
28. Cole DK, Rizkallah PJ, Gao F, et al. Crystal structure of HLA-A&z. ast;2402 complexed with atelomerase peptide. Eur J Immunol. 2006;36(1):170-179. (Pubitemid 43116403)
29. Burrows JM, Bell MJ, Brennan R, Miles JJ, Khanna R, Burrows SR. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition. Mol Immunol. 2008;45(6):1818-1824. (Pubitemid 351221138)
30. Bell MJ, Burrows JM, Brennan R, et al. The peptide length specificity of some HLAclass I alleles is very broad and includes peptides of up to 25 amino acids in length. Mol Immunol. 2009; 46(8-9):1911-1917.
31. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature. 1987;326(6116): 881-882. (Pubitemid 17065301)
32. Sidney J, Assarsson E, Moore C, et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 2008;4:2.
33. Cole DK, Yuan F, Rizkallah PJ, et al. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem. 2009;284(40):27281-27289.
34. Green KJ, Miles JJ, Tellam J, van Zuylen WJ, Connolly G, Burrows SR. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur J Immunol. 2004;34(9): 2510-2519. (Pubitemid 39302808)
35. Sliz P, Michielin O, Cerottini JC, et al. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol. 2001; 167(6):3276-3284. (Pubitemid 32852568)
36. Bulek AM, Cole DK, Skowera A, et al. Structural basis for the killing of human beta cells by CD8(+) Tcells in type 1 diabetes. Nat Immunol. 2012;13(3): 283-289.
37. Gras S, Chen Z, Miles JJ, et al. Allelic polymor-phism in the T cell receptor and its impact on immune responses. J Exp Med. 2010;207(7):1555-1567.
38. Burrows JM, Wynn KK, Tynan FE, et al. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV. Eur J Immunol. 2007;37(4):946-953. (Pubitemid 46925332)
39. Smith KJ, Reid SW, Stuart DI, McMichael AJ, Jones EY, Bell JI. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B&z. ast;3501. Immunity. 1996;4(3): 203-213.
40. Probst-Kepper M, Hecht HJ, Herrmann H, et al. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B&z. ast;3501. J Immunol. 2004;173(9):5610-5616. (Pubitemid 39392148)
41. Borg NA, Wun KS, Kjer-Nielsen L, et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature. 2007;448(7149):44-49. (Pubitemid 47037002)
42. Pellicci DG, Clarke AJ, Patel O, et al. Recognition of beta-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol. 2011; 12(9):827-833.
43. Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol. 2009;21(2):233-240.
44. Skipper JC, Gulden PH, Hendrickson RC, et al. Mass-spectrometric evaluation of HLA-A&z. ast;0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. Int J Cancer. 1999;82(5):669-677.
45. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeo-static proliferation in the periphery. Immunity. 1999;11(2):173-181. (Pubitemid 29428810)
46. Starr TK, Daniels MA, Lucido MM, Jameson SC, Hogquist KA. Thymocyte sensitivity and supra-molecular activation cluster formation are devel-opmentally regulated: a partial role for sialylation. J Immunol. 2003;171(9):4512-4520. (Pubitemid 37310566)
47. Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med. 1997; 186(8):1269-1275. (Pubitemid 27469022)
48. Seddon B, Zamoyska R. TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J Immunol. 2002;169(6): 2997-3005. (Pubitemid 35013142)
49. Miles JJ, Elhassen D, Borg NA, et al. CTL recognition of a bulged viral peptide involves biased TCR selection. J Immunol. 2005;175(6):3826-3834. (Pubitemid 41292043)
50. Tynan FE, Burrows SR, Buckle AM, et al. T cell receptor recognition of a 'super-bulged' major his-tocompatibility complex class I-bound peptide. Nat Immunol. 2005;6(11):1114-1122. (Pubitemid 41541789)